Strep, hearing loss, MS, and TAVR outcomes

from TT HealthWatch · host David Peregrino

Program notes:0:33 TAVR outcomes improved1:33 Dapagliflozin 2:33 Looked at comorbidities3:00 Tolebrutinib for relapsing MS4:00 Annualized relapse rate5:00 Works in the CNS6:00 First endpoint wasn't proven6:20 Invasive group A strep7:20 Become more resistant to antibiotics8:01 Not a single type of group A strep8:25 Hearing loss and heart failure9:25 Psychological distress mediiates10:25 With hearing aids, you would think it would go down11:20 Everything looks associated12:03 End

Episode metadata supplied by the publisher feed · Published Apr 18, 2025

Embed this episode

Attribution link and audio player

What this episode covers

This week's topics include group A strep in the U.S., hearing loss and heart failure, a new medicine for MS, and making TAVR outcomes better.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Strep, hearing loss, MS, and TAVR outcomes

0:00 12:03

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of TT HealthWatch?

This episode is 12 minutes long.

When was this TT HealthWatch episode published?

This episode was published on April 18, 2025.

Can I download this TT HealthWatch episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!